IPO5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.267600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.005600E-01
Normal-vs-Stage2
7.397800E-01
Normal-vs-Stage3
3.021500E-02
Normal-vs-Stage4
2.621600E-01
Stage1-vs-Stage2
5.676200E-01
Stage1-vs-Stage3
6.241800E-03
Stage1-vs-Stage4
2.384600E-01
Stage2-vs-Stage3
6.288200E-02
Stage2-vs-Stage4
2.243000E-01
Stage3-vs-Stage4
3.964900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.129200E-01
Normal-vs-AfricanAmerican
5.237600E-01
Normal-vs-Asian
2.794200E-01
Caucasian-vs-AfricanAmerican
1.234200E-01
Caucasian-vs-Asian
1.761400E-01
AfricanAmerican-vs-Asian
4.507700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.928600E-01
Normal-vs-Female
7.860000E-01
Male-vs-Female
6.129000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.336600E-01
Normal-vs-Age(41-60Yrs)
9.443000E-01
Normal-vs-Age(61-80Yrs)
5.970400E-01
Normal-vs-Age(81-100Yrs)
9.591200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.394400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.859400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.726400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.819800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.053000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.695200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.761000E-01
Normal-vs-Daily Drinker
1.715790E-01
Normal-vs-Weekly Drinker
6.829400E-01
Normal-vs-Occasional Drinker
9.502400E-01
Normal-vs-Social Drinker
9.485400E-01
Non Drinker-vs-Daily Drinker
3.722200E-01
Non Drinker-vs-Weekly Drinker
4.978000E-01
Non Drinker-vs-Occasional Drinker
1.203000E-01
Non Drinker-vs-Social Drinker
1.662770E-01
Daily Drinker-vs-Weekly Drinker
1.163190E-01
Daily Drinker-vs-Occasional Drinker
1.374480E-02
Daily Drinker-vs-Social Drinker
3.258300E-02
Weekly Drinker-vs-Occasional Drinker
4.387400E-01
Weekly Drinker-vs-Social Drinker
4.984600E-01
Occasional Drinker-vs-Social Drinker
9.773200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.799000E-01
Normal-vs-Grade 2
9.838400E-01
Normal-vs-Grade 3
9.684000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.452400E-01
Grade 1-vs-Grade 3
4.755000E-01
Grade 1-vs-Grade 4
9.799000E-01
Grade 2-vs-Grade 3
3.384600E-01
Grade 2-vs-Grade 4
9.838400E-01
Grade 3-vs-Grade 4
9.684000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.386000E-01
Normal-vs-NonDiabetic
5.697000E-01
Diabetic-vs-NonDiabetic
8.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.821000E-01
Normal-vs-NoPancreatitis
6.428400E-01
Pancreatitis-vs-NoPancreatitis
6.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.081800E-01
Normal-vs-N1
7.547800E-01
N0-vs-N1
8.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.286600E-01
Normal-vs-TP53-NonMutant
9.467800E-01
TP53-Mutant-vs-TP53-NonMutant
5.971600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
